Literature DB >> 23266831

Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient.

Yahong Nie1, Yingjuan Sun, Yun Wang, Chengyu Liu, Chengquan Zhao, Bing Luo.   

Abstract

In most previous studies, comparisons of Epstein-Barr virus (EBV) gene polymorphisms and genotypes were made between strains from tumors and normal throat washings (TWs) from different individuals. However, it remains controversial whether different EBV subtypes are present in different parts of the same NPC patient. In order to address this question, in this study, we compared the genotypes in sets of paired throat washings (TW) and paraffin-embedded tissues of 20 patients with nasopharyngeal carcinoma (NPC), and we found the same genotype in throat washings (TWs) and tumor cells from the same individual in most cases. The subtypes of EBER and EBNA1 genes were furthermore sequenced, and identical EBV strains were identified in tumor tissues and TWs. In conclusion, different sites of the same individual are infected by the same EBV strains, except for a few differences in occasional cases, suggesting that the EBV subtype detected in throat washings is a reasonable guide to the subtype present in the carcinoma tissue.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266831     DOI: 10.1007/s00705-012-1578-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

1.  Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk.

Authors:  Kemin Cai; Yu Wang; Xiaojun Zhao; Xueli Bao
Journal:  Tumour Biol       Date:  2013-10-11

2.  High prevalence of the EBER variant EB-8m in endemic nasopharyngeal carcinomas.

Authors:  Zhi-chao Shen; Bing Luo; Jian-ning Chen; Yan Chao; Chun-kui Shao; Qian-qian Liu; Yun Wang
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

3.  Associations of Epstein-Barr Virus DNA in PBMCs and the Subtypes with Breast Cancer Risk.

Authors:  Wei Zhang; Min-Yi Wang; Xue-Ling Wei; Ying Lin; Feng-Xi Su; Xiao-Ming Xie; Lu-Ying Tang; Ze-Fang Ren
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.